title: Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
authors.forename: Katherine A
authors.initials: KA
authors.lastname: Laessig
authors.forename: Linda L
authors.initials: LL
authors.lastname: Lewis
authors.forename: Thomas S
authors.initials: TS
authors.lastname: Hammerstrom
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D015982:Bias; D003627:Data Interpretation, Statistical; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000068679:Emtricitabine; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D063065:Organophosphonates / Q000627:therapeutic use; D012107:Research Design; D000068698:Tenofovir; D015215:Zidovudine / Q000627:therapeutic use
chemical_list: D044966:Anti-Retroviral Agents; D063065:Organophosphonates; D003841:Deoxycytidine; D019259:Lamivudine; D015215:Zidovudine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine